PMID: 8586003May 1, 1995Paper

A longitudinal study of plasma insulin and glucagon in women with previous gestational diabetes

Diabetes Care
P DammL Mølsted-Pedersen

Abstract

To investigate whether plasma insulin or glucagon predicts later development of diabetes in women with gestational diabetes mellitus (GDM). The subjects studied were 91 women with diet-treated GDM and 33 healthy women. Plasma insulin and glucagon during a 50-g oral glucose tolerance test (OGTT) were measured during pregnancy, postpartum, and at follow-up 5-11 years later. At follow-up, the women were also examined with a 75-g OGTT or an intravenous glucagon test. Twenty-seven (30%) of the women with previous GDM had abnormal glucose tolerance at follow-up (2 had insulin-dependent diabetes mellitus, 13 had non-insulin-dependent diabetes mellitus, and 12 had impaired glucose tolerance). Compared with the control subjects, women with previous GDM had relatively impaired insulin secretion (decreased insulinogenic index and delayed peak insulin response) at all time points investigated; this was also found when only nonobese glucose-tolerant women were examined. Low insulin secretion during pregnancy together with a high fasting plasma glucose level at the diagnostic OGTT in pregnancy and hyperglycemia during the postpartum OGTT were predictive for subsequent development of overt diabetes (logistic regression analysis). Women who de...Continue Reading

Citations

Jan 24, 2004·Diabetes Research and Clinical Practice·W P PimentaC R Padovani
Jan 5, 2000·Journal of Diabetes and Its Complications·C L DavisJ S Skyler
May 27, 2008·Molecular Therapy : the Journal of the American Society of Gene Therapy·Darin E OlsonPeter M Thulé
Feb 26, 2000·Journal of Internal Medicine·H Bar-OnG Friedman
Nov 10, 2000·Diabetic Medicine : a Journal of the British Diabetic Association·A CostaI Conget
Sep 26, 1996·The New England Journal of Medicine·F Davidson
Oct 28, 2003·Human Gene Therapy·Darin E OlsonPeter M Thulé
May 1, 1997·The Australian & New Zealand Journal of Obstetrics & Gynaecology·R MosesD Calvert
Oct 12, 2004·Epidemiology·Nicole L GlazerBeth A Mueller
Mar 6, 2012·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·Aneta Malinowska-PolubiecRoman Smolarczyk
Sep 24, 2005·Diabetic Medicine : a Journal of the British Diabetic Association·T BitóA Pál
Nov 19, 2004·Acta Obstetricia Et Gynecologica Scandinavica·Walkyria P PimentaCarlos Roberto Padovani
Jul 25, 2003·Diabetes/metabolism Research and Reviews·G Di CianniS Del Prato
Dec 18, 2007·BJOG : an International Journal of Obstetrics and Gynaecology·C RussellK S Joseph
Apr 4, 2007·American Journal of Obstetrics and Gynecology·Karen V SmirnakisJeffrey L Ecker
Dec 17, 2014·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·Yukari KugishimaNobuko Kusuda
Sep 28, 2002·Diabetes Care·Catherine KimRobert H Knopp
Mar 1, 1999·Asia Pacific Journal of Clinical Nutrition·B H Hsu-Hage, X Yang
Sep 18, 2018·Acta Diabetologica·Emilia HuvinenSaila B Koivusalo

❮ Previous
Next ❯

Related Concepts

Related Feeds

American Diabetes Association Journals

Discover the latest diabetes research published by the journals from the American Diabetes Association.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.